Flick Gocke Schaumburg advises MEDIQON Group AG on increasing cash capital and completing an investment agreement with a group of investors

Flick Gocke Schaumburg has advised MEDIQON Group AG on a cash capital increase from authorized capital, subject to an exclusion of subscription rights, and also on the negotiation and conclusion of an investment agreement with a group of institutional investors.

The shares were subscribed by a group of investors who also intend to exercise their subscription right in a further cash capital increase planned for 2022, and possibly acquire new shares which haven’t been subscribed by other shareholders.

The funds provided to the partnership through the capital increase are intended to further accelerate growth, as well as promote expansion and strengthen the capital structure at MEDIQON Group AG.

Advisors to MEDIQON Group AG (stock corporation and capital market law advice): Flick Gocke Schaumburg

Dr. Christian Bochmann (Partner); Associate: Dr. Denis C. Kaspras (both corporation and capital market law)

MEDIQON Group AG is based in Königstein in the Taunus district of central Germany and is a stock-listed holding company, combining talent and market opportunities. MEDIQON invests and supports decentralized platform subsidiaries with long-term capital enabling entrepreneurship and growth for many years to come. <<<